 |
|
|
| |
SOF/VEL/VOX for 12 Weeks is a Safe and Effective Salvage Regimen for NS5A Inhibitor-Experienced Patients with Genotype 1-6 HCV Infection: An Integrated Analysis of Phase 2 and Phase 3 Studies
|
| |
| |
at Digestive Disease Week
02nd - 05th June, 2018 Washington, D.C
Eric Lawitz1, Michael P. Manns2, Marc Bourlière3, Nelson Cheinquer4, Luisa M. Stamm4, Rob H. Hyland4, Liyun Ni4, Hadas Dvory-Sobol4, Diana M. Brainard4, G. Mani Subramanian4, Edward J. Gane5
1Texas Liver Institute, University of Texas Health San Antonio, San Antonio, TX, USA; 2Hannover Medical School, Hannover, Germany; 3Hopital Saint Joseph, Marseille, France; 4Gilead Sciences, Inc., Foster City, CA, USA; 5Auckland University, Auckland, New Zealand
|
| |
|
|
|
|
|
